Table 1 Antimicrobial susceptibility profiles for invasive (Wisconsin 1998–2002) and colonizing (Michigan 2001) group B streptococcal isolates
From: Frequency of antimicrobial resistance among invasive and colonizing Group B Streptococcal isolates
Invasive isolates (n= 486) | Colonizing isolates (n= 167) | |||||
|---|---|---|---|---|---|---|
Antibiotic | Susceptible % | Intermediate % | Resistant % | Susceptible % | Intermediate % | Resistant % |
Amplicillin | 100 | 0 | 0 | 100 | 0 | 0 |
Cefazolin | 99.4 | 0.6 | 0 | 99.4 | 0.6 | 0 |
Clindamycin | 80.0 | 0 | 20.0 | 59.3 | 0 | 40.71 |
Erythromycin | 75.5 | 0 | 24.5 | 58.1 | 0 | 41.91 |
Imipenem | 100 | 0 | 0 | 100 | 0 | 0 |
Levofloxacin | 99.6 | 0 | 0.4 | 99.4 | 0 | 0.6 |
Linezolid | 100 | 0 | 0 | 100 | 0 | 0 |
Penicillin | 100 | 0 | 0 | 100 | 0 | 0 |
Quinupristin-dalfopristin | 100 | 0 | 0 | 100 | 0 | 0 |
Vancomycin | 100 | 0 | 0 | 100 | 0 | 0 |